Complication of Coronary Artery Bypass Graft Clinical Trial
Official title:
Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG
A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01698372 -
Negative Pressure Dressing After Saphenous Vein Harvest
|
Phase 1 | |
Completed |
NCT02814084 -
Prevena Incision Management
|
N/A | |
Not yet recruiting |
NCT02554305 -
The Fusion Versus The Affinity Oxygenation Systems
|
N/A | |
Not yet recruiting |
NCT01457859 -
Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery
|
Phase 4 | |
Withdrawn |
NCT02035163 -
Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi
|
N/A | |
Completed |
NCT03612388 -
Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;
|
||
Recruiting |
NCT02711124 -
Relationship Between Level of Hemoglonin A1c and Platelet Function in Patients Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT01406483 -
Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting
|
N/A |